Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations

被引：257
|
作者：
Abdullah, Mardiaty Iryani [1 ,5 ]
Junit, Sarni Mat [1 ]
Ng, Khoon Leong [2 ]
Jayapalan, Jaime Jacqueline [3 ]
Karikalan, Barani [4 ]
Hashim, Onn Haji [1 ,3 ]
机构：
[1] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia
[2] Univ Malaya, Fac Med, Dept Surg, Kuala Lumpur 50603, Malaysia
[3] Univ Malaya, Ctr Prote Res, Fac Med, Kuala Lumpur 50603, Malaysia
[4] Perdana Univ, Jalan MAEPS Perdana, Serdang 43400, Selangor, Malaysia
[5] Int Islamic Univ Malaysia, Kulliyyah Allied Hlth Sci, Dept Biomed Sci, Kuantan 25200, Pahang, Malaysia
来源：
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES | 2019年 / 16卷 / 03期
关键词：
papillary thyroid cancer; molecular alteration; genetic signature; biomarker; diagnostics; FINE-NEEDLE-ASPIRATION; BRAF V600E MUTATION; ONCOGENE REARRANGEMENTS; EXPRESSION PROFILES; CLINICAL-FEATURES; TUMOR PROGRESSION; NUCLEAR FEATURES; GROWTH-FACTOR; UP-REGULATION; CARCINOMA;
D O I：
10.7150/ijms.29935
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Papillary thyroid cancer (PTC) is the most prevalent form of malignancy among all cancers of the thyroid. It is also one of the few cancers with a rapidly increasing incidence. PTC is usually contained within the thyroid gland and generally biologically indolent. Prognosis of the cancer is excellent, with less than 2% mortality at 5 years. However, more than 25% of patients with PTC developed a recurrence during a long term follow-up. The present article provides an updated condensed overview of PTC, which focuses mainly on the molecular alterations involved and recent biomarker investigations.
引用
收藏
页码：450 / 460
页数：11
相关论文
共 50 条
  • [1] Genetic Alterations in Hungarian Patients with Papillary Thyroid Cancer
    Tobias, Balint
    Halaszlaki, Csaba
    Balla, Bernadett
    Kosa, Janos P.
    Arvai, Kristof
    Horvath, Peter
    Takacs, Istvan
    Nagy, Zsolt
    Horvath, Evelin
    Horanyi, Janos
    Jaray, Balazs
    Szekely, Eszter
    Szekely, Tamas
    Gyori, Gabriella
    Putz, Zsuzsanna
    Dank, Magdolna
    Valkusz, Zsuzsanna
    Vasas, Bela
    Ivanyi, Bela
    Lakatos, Peter
    PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (01) : 27 - 33
  • [2] Serum miR-22 may be a biomarker for papillary thyroid cancer
    Wang, Deping
    Guo, Changxiu
    Kong, Tingting
    Mi, Guangxi
    Li, Jiantao
    Sun, Yuhan
    ONCOLOGY LETTERS, 2019, 17 (03) : 3355 - 3361
  • [3] Molecular Pathways Associated with Aggressiveness of Papillary Thyroid Cancer
    Benvenga, Salvatore
    Koch, Christian A.
    CURRENT GENOMICS, 2014, 15 (03) : 162 - 170
  • [4] MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer
    Dai, Lei
    Wang, Yaozong
    Chen, Liangliang
    Zheng, Jueru
    Li, Jianjun
    Wu, Xianjiang
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2017, 15
  • [5] Multiple Genetic Alterations in Papillary Thyroid Cancer are Associated with Younger Age at Presentation
    Moses, Willieford
    Weng, Julie
    Khanafshar, Elham
    Duh, Quan-Yang
    Clark, Orlo H.
    Kebebew, Electron
    JOURNAL OF SURGICAL RESEARCH, 2010, 160 (02) : 179 - 183
  • [6] Detection and Identification of Serum Peptides Biomarker in Papillary Thyroid Cancer
    Lu, Zhao-lian
    Chen, Ying-jian
    Jing, Xin-yan
    Wang, Na-na
    Zhang, Ting
    Hu, Cheng-jin
    MEDICAL SCIENCE MONITOR, 2018, 24 : 1581 - 1587
  • [7] Molecular Epidemiology of Papillary Thyroid Cancer: In Search of Common Genetic Associations
    Sturgis, Erich M.
    Li, Guojun
    THYROID, 2009, 19 (10) : 1031 - 1034
  • [8] Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer
    Lee, Min-Young
    Ku, Bo Mi
    Kim, Hae Su
    Lee, Ji Yun
    Lim, Sung Hee
    Sun, Jong-Mu
    Lee, Se-Hoon
    Park, Keunchil
    Oh, Young Lyun
    Hong, Mineui
    Jeong, Han-Sin
    Son, Young-Ik
    Baek, Chung-Hwan
    Ahn, Myung-Ju
    CANCER RESEARCH AND TREATMENT, 2017, 49 (04): : 906 - 914
  • [9] Annexin A10 is a novel prognostic biomarker of papillary thyroid cancer
    Xiaoyun Liu
    Meijing Yang
    Yang Guo
    Xiaofei Lu
    Irish Journal of Medical Science (1971 -), 2021, 190 : 59 - 65
  • [10] IL-34 is a potential biomarker for the treatment of papillary thyroid cancer
    Zhang, Ping
    Zhang, Hao
    Dong, Wenwu
    Wang, Zhihong
    Qin, Yuan
    Wu, Changhao
    Dong, Qi
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (08)
12345